HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-JUL-13 4LI8 TITLE TANKYRASE-1 COMPLEXED WITH SMALL MOLECULE INHIBITOR 2-[4-(4- TITLE 2 FLUOROBENZOYL)PIPERIDIN-1-YL]-N-[(4-OXO-3,5,7,8-TETRAHYDRO-4H- TITLE 3 PYRANO[4,3-D]PYRIMIDIN-2-YL)METHYL]-N-(THIOPHEN-2-YLMETHYL)ACETAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TANKYRASE-1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, UNP RESIDUES 1105-1325; COMPND 5 SYNONYM: TANK1, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 5, COMPND 6 ARTD5, POLY [ADP-RIBOSE] POLYMERASE 5A, TNKS-1, TRF1-INTERACTING COMPND 7 ANKYRIN-RELATED ADP-RIBOSE POLYMERASE, TANKYRASE I; COMPND 8 EC: 2.4.2.30; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.A.KIRBY,T.STAMS REVDAT 3 28-FEB-24 4LI8 1 REMARK SEQADV LINK REVDAT 2 02-OCT-13 4LI8 1 JRNL REVDAT 1 14-AUG-13 4LI8 0 JRNL AUTH M.D.SHULTZ,A.K.CHEUNG,C.A.KIRBY,B.FIRESTONE,J.FAN,C.H.CHEN, JRNL AUTH 2 Z.CHEN,D.N.CHIN,L.DIPIETRO,A.FAZAL,Y.FENG,P.D.FORTIN, JRNL AUTH 3 T.GOULD,B.LAGU,H.LEI,F.LENOIR,D.MAJUMDAR,E.OCHALA, JRNL AUTH 4 M.G.PALERMO,L.PHAM,M.PU,T.SMITH,T.STAMS,R.C.TOMLINSON, JRNL AUTH 5 B.B.TOURE,M.VISSER,R.M.WANG,N.J.WATERS,W.SHAO JRNL TITL IDENTIFICATION OF NVP-TNKS656: THE USE OF JRNL TITL 2 STRUCTURE-EFFICIENCY RELATIONSHIPS TO GENERATE A HIGHLY JRNL TITL 3 POTENT, SELECTIVE, AND ORALLY ACTIVE TANKYRASE INHIBITOR. JRNL REF J.MED.CHEM. V. 56 6495 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23844574 JRNL DOI 10.1021/JM400807N REMARK 2 REMARK 2 RESOLUTION. 2.52 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.52 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.04 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 3 NUMBER OF REFLECTIONS : 15321 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.283 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 766 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 2.7156 - 2.5210 0.82 0 133 0.2780 0.3823 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.84410 REMARK 3 B22 (A**2) : 18.10690 REMARK 3 B33 (A**2) : -21.95100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.75370 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 NULL REMARK 3 ANGLE : 0.939 NULL REMARK 3 CHIRALITY : 0.063 NULL REMARK 3 PLANARITY : 0.040 NULL REMARK 3 DIHEDRAL : 17.970 NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4LI8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUL-13. REMARK 100 THE DEPOSITION ID IS D_1000080662. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15321 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.521 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.170 REMARK 200 R MERGE (I) : 0.10500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.52 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.25 REMARK 200 R MERGE FOR SHELL (I) : 0.35300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.570 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER METHODS REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: EQUAL VOLUMES (2 UL) OF RESERVIOR REMARK 280 SOLUTION AND PROTEIN SOLUTION WERE MIXED AND SET AS HANGING REMARK 280 DROPS. 15% PEG3350, 100MM BIS-TRIS PH5.8, 310MM AMMONIUM REMARK 280 SULFATE. PROTEIN SOLUTION: 20 MG/ML IN 25 MM TRIS PH8, 200MM REMARK 280 NACL, 1MM TCEP, 1MM PJ34. CRYSTALS WERE THEN MOVED INTO A REMARK 280 SOAKING SOLUTION CONTAINING 18% PEG 3350, 320MM AMMONIUM SULFATE, REMARK 280 100MM BIS- TRIS PH 5.8, 0.2 MM INHIBITOR. , VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 62.35000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.55000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 62.35000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 21.55000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1104 REMARK 465 TYR A 1203 REMARK 465 ILE A 1204 REMARK 465 GLY A 1205 REMARK 465 PRO A 1282 REMARK 465 SER A 1283 REMARK 465 VAL A 1284 REMARK 465 ASN A 1285 REMARK 465 GLY A 1286 REMARK 465 LEU A 1287 REMARK 465 ALA A 1288 REMARK 465 GLU A 1314 REMARK 465 ALA A 1315 REMARK 465 PRO A 1316 REMARK 465 SER A 1317 REMARK 465 GLN A 1318 REMARK 465 THR A 1319 REMARK 465 ALA A 1320 REMARK 465 THR A 1321 REMARK 465 ALA A 1322 REMARK 465 ALA A 1323 REMARK 465 GLU A 1324 REMARK 465 GLN A 1325 REMARK 465 LYS A 1326 REMARK 465 THR A 1327 REMARK 465 GLY B 1104 REMARK 465 TYR B 1203 REMARK 465 ILE B 1204 REMARK 465 GLY B 1205 REMARK 465 ALA B 1315 REMARK 465 PRO B 1316 REMARK 465 SER B 1317 REMARK 465 GLN B 1318 REMARK 465 THR B 1319 REMARK 465 ALA B 1320 REMARK 465 THR B 1321 REMARK 465 ALA B 1322 REMARK 465 ALA B 1323 REMARK 465 GLU B 1324 REMARK 465 GLN B 1325 REMARK 465 LYS B 1326 REMARK 465 THR B 1327 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A1173 49.51 -143.57 REMARK 500 LYS A1195 -5.21 -143.59 REMARK 500 ASP B1134 0.47 -63.19 REMARK 500 ASN B1173 39.92 -146.05 REMARK 500 PRO B1302 71.98 -68.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A1234 SG REMARK 620 2 HIS A1237 ND1 111.6 REMARK 620 3 CYS A1242 SG 120.2 106.1 REMARK 620 4 CYS A1245 SG 116.5 93.2 105.5 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B1234 SG REMARK 620 2 HIS B1237 ND1 103.6 REMARK 620 3 CYS B1242 SG 109.0 131.7 REMARK 620 4 CYS B1245 SG 89.4 98.6 116.1 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1XQ A 1402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1XQ B 1402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4LI6 RELATED DB: PDB REMARK 900 RELATED ID: 4LI7 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE CONFLICT M1266I PRESENT IN UNP ENTRY O95271 DBREF 4LI8 A 1105 1327 UNP O95271 TNKS1_HUMAN 1105 1327 DBREF 4LI8 B 1105 1327 UNP O95271 TNKS1_HUMAN 1105 1327 SEQADV 4LI8 GLY A 1104 UNP O95271 EXPRESSION TAG SEQADV 4LI8 ILE A 1266 UNP O95271 MET 1266 SEE REMARK 999 SEQADV 4LI8 GLY B 1104 UNP O95271 EXPRESSION TAG SEQADV 4LI8 ILE B 1266 UNP O95271 MET 1266 SEE REMARK 999 SEQRES 1 A 224 GLY GLY THR ILE LEU LEU ASP LEU ALA PRO GLU ASP LYS SEQRES 2 A 224 GLU TYR GLN SER VAL GLU GLU GLU MET GLN SER THR ILE SEQRES 3 A 224 ARG GLU HIS ARG ASP GLY GLY ASN ALA GLY GLY ILE PHE SEQRES 4 A 224 ASN ARG TYR ASN VAL ILE ARG ILE GLN LYS VAL VAL ASN SEQRES 5 A 224 LYS LYS LEU ARG GLU ARG PHE CYS HIS ARG GLN LYS GLU SEQRES 6 A 224 VAL SER GLU GLU ASN HIS ASN HIS HIS ASN GLU ARG MET SEQRES 7 A 224 LEU PHE HIS GLY SER PRO PHE ILE ASN ALA ILE ILE HIS SEQRES 8 A 224 LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY GLY MET SEQRES 9 A 224 PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SER LYS SEQRES 10 A 224 SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY THR GLY SEQRES 11 A 224 CYS PRO THR HIS LYS ASP ARG SER CYS TYR ILE CYS HIS SEQRES 12 A 224 ARG GLN MET LEU PHE CYS ARG VAL THR LEU GLY LYS SER SEQRES 13 A 224 PHE LEU GLN PHE SER THR ILE LYS MET ALA HIS ALA PRO SEQRES 14 A 224 PRO GLY HIS HIS SER VAL ILE GLY ARG PRO SER VAL ASN SEQRES 15 A 224 GLY LEU ALA TYR ALA GLU TYR VAL ILE TYR ARG GLY GLU SEQRES 16 A 224 GLN ALA TYR PRO GLU TYR LEU ILE THR TYR GLN ILE MET SEQRES 17 A 224 LYS PRO GLU ALA PRO SER GLN THR ALA THR ALA ALA GLU SEQRES 18 A 224 GLN LYS THR SEQRES 1 B 224 GLY GLY THR ILE LEU LEU ASP LEU ALA PRO GLU ASP LYS SEQRES 2 B 224 GLU TYR GLN SER VAL GLU GLU GLU MET GLN SER THR ILE SEQRES 3 B 224 ARG GLU HIS ARG ASP GLY GLY ASN ALA GLY GLY ILE PHE SEQRES 4 B 224 ASN ARG TYR ASN VAL ILE ARG ILE GLN LYS VAL VAL ASN SEQRES 5 B 224 LYS LYS LEU ARG GLU ARG PHE CYS HIS ARG GLN LYS GLU SEQRES 6 B 224 VAL SER GLU GLU ASN HIS ASN HIS HIS ASN GLU ARG MET SEQRES 7 B 224 LEU PHE HIS GLY SER PRO PHE ILE ASN ALA ILE ILE HIS SEQRES 8 B 224 LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY GLY MET SEQRES 9 B 224 PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SER LYS SEQRES 10 B 224 SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY THR GLY SEQRES 11 B 224 CYS PRO THR HIS LYS ASP ARG SER CYS TYR ILE CYS HIS SEQRES 12 B 224 ARG GLN MET LEU PHE CYS ARG VAL THR LEU GLY LYS SER SEQRES 13 B 224 PHE LEU GLN PHE SER THR ILE LYS MET ALA HIS ALA PRO SEQRES 14 B 224 PRO GLY HIS HIS SER VAL ILE GLY ARG PRO SER VAL ASN SEQRES 15 B 224 GLY LEU ALA TYR ALA GLU TYR VAL ILE TYR ARG GLY GLU SEQRES 16 B 224 GLN ALA TYR PRO GLU TYR LEU ILE THR TYR GLN ILE MET SEQRES 17 B 224 LYS PRO GLU ALA PRO SER GLN THR ALA THR ALA ALA GLU SEQRES 18 B 224 GLN LYS THR HET ZN A1401 1 HET 1XQ A1402 37 HET SO4 A1403 5 HET SO4 A1404 5 HET SO4 A1405 5 HET ZN B1401 1 HET 1XQ B1402 37 HET SO4 B1403 5 HETNAM ZN ZINC ION HETNAM 1XQ 2-[4-(4-FLUOROBENZOYL)PIPERIDIN-1-YL]-N-[(4-OXO-3,5,7, HETNAM 2 1XQ 8-TETRAHYDRO-4H-PYRANO[4,3-D]PYRIMIDIN-2-YL)METHYL]-N- HETNAM 3 1XQ (THIOPHEN-2-YLMETHYL)ACETAMIDE HETNAM SO4 SULFATE ION FORMUL 3 ZN 2(ZN 2+) FORMUL 4 1XQ 2(C27 H29 F N4 O4 S) FORMUL 5 SO4 4(O4 S 2-) FORMUL 11 HOH *88(H2 O) HELIX 1 1 ASP A 1115 THR A 1128 1 14 HELIX 2 2 LYS A 1156 GLU A 1172 1 17 HELIX 3 3 PHE A 1188 GLY A 1196 1 9 HELIX 4 4 ASN A 1217 GLN A 1223 1 7 HELIX 5 5 GLY A 1227 GLY A 1231 5 5 HELIX 6 6 ARG A 1296 GLU A 1298 5 3 HELIX 7 7 ASP B 1115 THR B 1128 1 14 HELIX 8 8 ASN B 1155 GLU B 1172 1 18 HELIX 9 9 PHE B 1188 GLY B 1196 1 9 HELIX 10 10 ASP B 1198 ALA B 1202 5 5 HELIX 11 11 ASN B 1217 GLN B 1223 1 7 HELIX 12 12 GLY B 1227 GLY B 1231 5 5 HELIX 13 13 ARG B 1296 GLU B 1298 5 3 SHEET 1 A 5 THR A1106 ASP A1110 0 SHEET 2 A 5 ARG A1144 ASN A1155 -1 O LYS A1152 N LEU A1109 SHEET 3 A 5 ALA A1300 MET A1311 -1 O GLN A1309 N ASN A1146 SHEET 4 A 5 ARG A1247 THR A1255 -1 N ARG A1247 O TYR A1308 SHEET 5 A 5 GLU A1179 HIS A1184 -1 N ARG A1180 O VAL A1254 SHEET 1 B 4 ILE A1212 PHE A1214 0 SHEET 2 B 4 GLU A1291 ILE A1294 -1 O ILE A1294 N ILE A1212 SHEET 3 B 4 SER A1277 GLY A1280 -1 N GLY A1280 O GLU A1291 SHEET 4 B 4 SER A1259 GLN A1262 1 N PHE A1260 O ILE A1279 SHEET 1 C 5 ILE B1107 ASP B1110 0 SHEET 2 C 5 ARG B1144 VAL B1154 -1 O LYS B1152 N LEU B1109 SHEET 3 C 5 ALA B1300 MET B1311 -1 O GLN B1309 N ASN B1146 SHEET 4 C 5 ARG B1247 THR B1255 -1 N ARG B1253 O TYR B1301 SHEET 5 C 5 GLU B1179 HIS B1184 -1 N LEU B1182 O CYS B1252 SHEET 1 D 4 ILE B1212 PHE B1214 0 SHEET 2 D 4 GLU B1291 ILE B1294 -1 O ILE B1294 N ILE B1212 SHEET 3 D 4 SER B1277 GLY B1280 -1 N VAL B1278 O VAL B1293 SHEET 4 D 4 SER B1259 GLN B1262 1 N PHE B1260 O ILE B1279 LINK SG CYS A1234 ZN ZN A1401 1555 1555 2.32 LINK ND1 HIS A1237 ZN ZN A1401 1555 1555 2.36 LINK SG CYS A1242 ZN ZN A1401 1555 1555 2.39 LINK SG CYS A1245 ZN ZN A1401 1555 1555 2.53 LINK SG CYS B1234 ZN ZN B1401 1555 1555 2.55 LINK ND1 HIS B1237 ZN ZN B1401 1555 1555 2.39 LINK SG CYS B1242 ZN ZN B1401 1555 1555 2.23 LINK SG CYS B1245 ZN ZN B1401 1555 1555 2.35 SITE 1 AC1 4 CYS A1234 HIS A1237 CYS A1242 CYS A1245 SITE 1 AC2 17 HIS A1184 GLY A1185 PHE A1188 ALA A1191 SITE 2 AC2 17 PHE A1197 ASP A1198 HIS A1201 ALA A1202 SITE 3 AC2 17 GLY A1211 TYR A1213 PHE A1214 ALA A1215 SITE 4 AC2 17 LYS A1220 SER A1221 TYR A1224 ILE A1228 SITE 5 AC2 17 GLU A1291 SITE 1 AC3 6 HIS A1176 HIS A1177 ASN A1178 GLU A1179 SITE 2 AC3 6 HOH A1533 HIS B1176 SITE 1 AC4 6 ARG A1130 HIS A1132 ARG A1133 LYS A1220 SITE 2 AC4 6 GLN A1223 HOH A1531 SITE 1 AC5 5 HIS A1176 HOH A1532 HIS B1176 HIS B1177 SITE 2 AC5 5 ASN B1178 SITE 1 AC6 4 CYS B1234 HIS B1237 CYS B1242 CYS B1245 SITE 1 AC7 19 HIS B1184 GLY B1185 SER B1186 PHE B1188 SITE 2 AC7 19 ALA B1191 ILE B1192 PHE B1197 ASP B1198 SITE 3 AC7 19 HIS B1201 ALA B1202 GLY B1211 TYR B1213 SITE 4 AC7 19 PHE B1214 ALA B1215 LYS B1220 SER B1221 SITE 5 AC7 19 TYR B1224 ILE B1228 GLU B1291 SITE 1 AC8 6 ARG B1130 HIS B1132 ARG B1133 LYS B1220 SITE 2 AC8 6 GLN B1223 HOH B1503 CRYST1 124.700 43.100 88.100 90.00 91.30 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008019 0.000000 0.000182 0.00000 SCALE2 0.000000 0.023202 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011354 0.00000